Endocrinology & Metabolic Syndrome
Open Access

Richard Kones

Biography

Dr Richard Kones attended NYU School of Engineering, and then earned his MD degree at NYU School of Medicine in a special pilot program. As a medical student he conducted independent research on mechanisms of aldosterone, and became a full member of the New York Academy of Sciences. After completing clinical training in New York hospitals he completed a NIH Fellowship in cardiology at Tulane University School of Medicine in New Orleans. He returned to New York Medical College to continue work on actions of inotropic agents, myocardial function, preservation of ischemic myocardium, and cardiogenic shock, eventually relocating in Texas. An avid supporter of physiology in teaching and translational research, he has delivered presentations, lectured, published, and enjoyed mentoring medical students and house staff at several medical schools and affiliated hospitals. He serves on a number of committees in various medical organizations, peer reviews for a variety of medical journals, and volunteers for the mentoring programs in the American Society for Clinical Pharmacology and Therapeutics and American Heart Association. Over the years Dr. Kones’ bio has appeared in a number of editions of Who’s Who, he is a founding editor and board member of Medpedia online, a collaborative educational project among several medical schools. He is a Fellow of the American Heart Association Council on Basic Science, the New York Cardiological Society, now merged with the New York Chapter of the American College of Cardiology, European Society of Cardiology, Royal Society of Medicine, the Royal Society of Public Health, American College of Pharmacology, and a Founding Fellow of the American Geriatrics Society. He is an Emeritus member of the American Physiological Society, American College of Sportsmedicine, and Endocrine Society. Other affiliations include the Physiological Society (London), Society for Critical Care Medicine, The Nutrition Society (London), European Atherosclerosis Society, National Lipid Association, American Diabetes Association, Endocrine Society, American and European Cardiovascular and Pulmonary Rehabilitation Societies, among many other notable scientific organizations and working groups. His interests gradually turned to pathological signaling in the atherothrombosis, especially the interaction of inflammatory mechanisms, endothelial dysfunction, mitochondrial involvement, lipid metabolism, metabolic syndrome and related evidence-based interventions to improve clinical outcomes. Fundamental molecular and cellular mechanisms in cardiometabolic disease have been central to his interests, as well as the practical aspects of how simple lifestyle and dietary changes may be powerful tools to minimize risk factors in the general population—primordial prevention.

Research Interest

His interests gradually turned to pathological signaling in the atherothrombosis, especially the interaction of inflammatory mechanisms, endothelial dysfunction, mitochondrial involvement, lipid metabolism, metabolic syndrome and related evidence-based interventions to improve clinical outcomes. Fundamental molecular and cellular mechanisms in cardiometabolic disease have been central to his interests, as well as the practical aspects of how simple lifestyle and dietary changes may be powerful tools to minimize risk factors in the general population—primordial prevention.